Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells

<p>Graphical abstract. A multi-omics analysis of the glioblastoma tumor microenvironment revealed that biglycan, predominantly expressed by inflammatory BTICs, drives tumor growth. The graphics were generated with Biorender.com.</p>

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Reza Mirzaei (15306062) (author)
Άλλοι συγγραφείς:	Charlotte D'Mello (15306065) (author), Marina Liu (15306068) (author), Ana Nikolic (15306071) (author), Mehul Kumar (15306074) (author), Frank Visser (15306077) (author), Pinaki Bose (15306080) (author), Marco Gallo (8808401) (author), V. Wee Yong (15306083) (author)
Έκδοση:	2025
Θέματα:	Cancer Tumor Biology Molecular and Cellular Biology CNS Cancers Gliomas, Glioblastomas Stem Cell Biology Cancer stem cells Tumor Heterogeneity
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
ανά: Reza Mirzaei (15306062)
Έκδοση: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
ανά: Reza Mirzaei (15306062)
Έκδοση: (2025)

Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
ανά: Michael Kilian (16697663)
Έκδοση: (2025)

Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
ανά: Michael Kilian (16697663)
Έκδοση: (2025)

Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
ανά: Michael Kilian (16697663)
Έκδοση: (2025)

Supplementary Figures from Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
ανά: Defne Bayik (14961098)
Έκδοση: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
ανά: Lanpeng Chen (16918293)
Έκδοση: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
ανά: Isha Mondal (16721699)
Έκδοση: (2025)

Supplementary video from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Table S1 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Table S2 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Table S3 from Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
ανά: Min Wu (14962986)
Έκδοση: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
ανά: Zhongyi Zhang (219440)
Έκδοση: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
ανά: Zhongyi Zhang (219440)
Έκδοση: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
ανά: Francesca Orzan (15055579)
Έκδοση: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
ανά: Francesca Orzan (15055579)
Έκδοση: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
ανά: Francesca Orzan (15055579)
Έκδοση: (2025)

Graphical abstract.
ανά: Ji-Xin Zhao (22056386)
Έκδοση: (2025)

Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
ανά: Sied Kebir (15048732)
Έκδοση: (2025)

Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
ανά: Sied Kebir (15048732)
Έκδοση: (2025)

Supplementary Figure S3 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
ανά: Sied Kebir (15048732)
Έκδοση: (2025)

Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
ανά: Sied Kebir (15048732)
Έκδοση: (2025)

Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
ανά: Sied Kebir (15048732)
Έκδοση: (2025)

Table S2 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Table S3 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Table S4 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Table S5 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Table S7 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Table S8 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
ανά: Joseph Toker (15399882)
Έκδοση: (2025)

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
ανά: Takeru Oka (15386810)
Έκδοση: (2025)

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
ανά: Takeru Oka (15386810)
Έκδοση: (2025)

Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
ανά: Qingsheng Xu (17078830)
Έκδοση: (2025)

Supplementary Table S3 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
ανά: Qingsheng Xu (17078830)
Έκδοση: (2025)

Cannot write session to /tmp/vufind_sessions/sess_mgdhrkg0b7kdklmr6r4lkd6t7i